“…Licorice and glycyrrhizin have also been markedly effective against SARS-CoV(Cinatl et al, 2003;Parvaiz et al, 2014), hepatitis C(Miyake et al, 2002) and upper respiratory tract infection(Yanagawa, Ogura, Fujimoto, Shono, & Okuda, 2004).β-glycyrrhizic acid is a potent anti-inflammatory compound in licorice that controls inflammation by inhibiting glucocorticoid accumulation and ROS production by neutrophils as strong mediators of tissue inflammation(Parvaiz et al, 2014). In a randomized trial, adding licorice (capsule 500 mg twice daily) to the long-acting betaagonist regimen in chronic stable moderate bronchial asthmatic patients significantly improved Forced Vital Capacity (FVC) % and Forced Expiratory Volume1 (FEV1)(Sadek, Tawfik, Hussein, & Abdelhakeem, 2019). A molecular docking study has demonstrated that glycyrrhizic acid have high binding affinity of À8.0 Kcal/mol and strong inhibitors for M pro of SARS-CoV2(Srivastava, Yadav, & Sarkar, 2020).Main pharmacological properties of N. sativa and its chemical constituents are antiviral(Salem & Hossain, 2000), anti-inflammatory, immunomodulatory(Forouzanfar, Bazzaz, & Hosseinzadeh, 2014), andF I G U R E1 HPLC chromatograms of ellagic acid (a), emodin (b), glycyrrhizin (c), apigenin (d) thymoquinone (e) in formulations anti-cough (Hosseinzadeh, Eskandari, & Ziaee, 2008) effects.…”